Skip to Content
Merck
All Photos(1)

Documents

AP101P

Sigma-Aldrich

Rabbit Anti-Human IgG Antibody, HRP conjugate

Chemicon®, from rabbit

Sign Into View Organizational & Contract Pricing


About This Item

UNSPSC Code:
12352203
eCl@ss:
32160702
NACRES:
NA.46

biological source

rabbit

Quality Level

conjugate

peroxidase conjugate

antibody form

F(ab′)2 fragment of affinity isolated antibody

antibody product type

secondary antibodies

clone

polyclonal

species reactivity

human

manufacturer/tradename

Chemicon®

technique(s)

ELISA: suitable
western blot: suitable

shipped in

wet ice

target post-translational modification

unmodified

Related Categories

Application

Detect Human IgG using this Rabbit anti-Human IgG Antibody, HRP conjugate validated for use in ELISA & WB.

Legal Information

CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany

Not finding the right product?  

Try our Product Selector Tool.

Storage Class Code

11 - Combustible Solids

WGK

WGK 3


Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Bibek Parajuli et al.
Biochemistry, 55(44), 6100-6114 (2016-10-13)
We recently reported the discovery of a recombinant chimera, denoted DAVEI (dual-acting virucidal entry inhibitor), which is able to selectively cause specific and potent lytic inactivation of both pseudotyped and fully infectious human immunodeficiency virus (HIV-1) virions. The chimera is
Ghadeer Alhamar et al.
The Journal of clinical endocrinology and metabolism, 108(7), e474-e479 (2023-01-08)
Poor glucose control has been associated with increased mortality in COVID-19 patients with type 1 diabetes (T1D). This work aimed to assess the effect of prevaccination glucose control on antibody response to the SARS-CoV-2 vaccine BNT162b2 in T1D. We studied
Antigen discovery by bioinformatics analysis and peptide microarray for the diagnosis of cystic echinococcosis.
Batisti Biffignandi, et al.
PLoS Neglected Tropical Diseases, 17, e0011210-e0011210 (2023)
Kasopefoluwa Y Oguntuyo et al.
medRxiv : the preprint server for health sciences (2020-08-21)
The global COVID-19 pandemic has mobilized efforts to develop vaccines and antibody-based therapeutics, including convalescent plasma therapy, that inhibit viral entry by inducing or transferring neutralizing antibodies (nAbs) against the SARS-CoV-2 spike glycoprotein (CoV2-S). However, rigorous efficacy testing requires extensive
Bibek Parajuli et al.
The Biochemical journal, 475(5), 931-957 (2018-01-19)
We previously reported a first-generation recombinant DAVEI construct, a dual action virus entry inhibitor composed of cyanovirin-N (CVN) fused to a membrane proximal external region or its derivative peptide Trp3. DAVEI exhibits potent and irreversible inactivation of HIV-1 (human immunodeficiency

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service